Pharnext's Series B - II Round

Pharnext raised a round of funding on February 09, 2012.

Pharnext specializes in the development of drugs based on PleotherapyTM for the treatment of severe, rare and common neurological diseases (including Alzheimer, Charcot-Marie Tooth disease, Parkinson'…

Articles about Pharnext's Series B - II Round: